Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Targeting Survivin with YM155 As a Potential Therapy in Pediatric Acute Lymphoblastic Leukemia

Abdusebur Jemal, Jeffrey W Tyner, PhD, Mathew Thayer, PhD, Markus Muschen, MD, PhD, Brian J. Druker, Bill H Chang, MD, PhD

Blood (2011) 118 (21): 2490.

https://doi.org/10.1182/blood.V118.21.2490.2490

Published: 2011

Journal Articles

Curcumin Prevents Cytokine-Mediated Tissue Factor Pathway Inhibitor Down-Regulation in Human Endothelial Cells

Keiko Maruyama, Eriko Morishita, MD, PhD, Yukie Goto, Akiko Sekiya, Hidesaku Asakura, MD, PhD, Shigeki Ohtake, MD, PhD, Shinji Nakao, MD, PhD

Blood (2011) 118 (21): 1202.

https://doi.org/10.1182/blood.V118.21.1202.1202

Published: 2011

Journal Articles

Curcumin Down-Regulates Cytokine-Mediated Tissue Factor and Plasminogen Activator Type 1 Expression In Human Endothelial Cells

Eriko Morishita, MD, PhD, Keiko Maruyama, Hidesaku Asakura, MD, PhD, Shigeki Ohtake, MD, PhD, Akihiro Yachie, MD, PhD, Shinji Nakao, MD, PhD

Blood (2010) 116 (21): 3333.

https://doi.org/10.1182/blood.V116.21.3333.3333

Published: 2010

Journal Articles

RNAi Identifies Survivin as a Potential Target for Therapy In Pediatric Acute Lymphoblastic Leukemia

Bill H Chang, MD, PhD, Jeffrey W Tyner, PhD, Abdusebur Jemal, Mathew Thayer, PhD, Brian J Druker, MD

Blood (2010) 116 (21): 5108.

https://doi.org/10.1182/blood.V116.21.5108.5108

Published: 2010

Journal Articles

Synergistic Anticancer Effects between Curcumin and Doxorubicin in Drug Sensitive and Resistant Human Pediatric Leukemic Cell Lines.

Cheppail Ramachandran, PhD, P.K. Raveendran Nair, Ph.D., Enrique Escalon, MD, Steven J. Melnick, Ph.D, MD, Ziad Khatib, MD

Blood (2006) 108 (11): 4361.

https://doi.org/10.1182/blood.V108.11.4361.4361

Published: 2006

Journal Articles

A Novel Ring-Substituted Diindolylmethane 1,1-bis [3′-(5-methoxyindolyl)]-1-(p-t-butylphenyl) Methane Abrogates ERK Activation and Induces Apoptosis in Acute Myeloid Leukemia (AML).

Rooha Contractor, Ismael J. Samudio, Ph.D., Zeev Estrov, M.D., David Harris, James A. McCubrey, Ph.D., Stephen H. Safe, Ph.D., Michael Andreeff, M.D., Ph.D., Marina Konopleva, M.D., Ph.D.

Blood (2004) 104 (11): 3399.

https://doi.org/10.1182/blood.V104.11.3399.3399

Published: 2004

Journal Articles

Sulfur- and Selenium-Containing Compounds Derived from Natural and Synthetic Sources in Angiogenesis Modulation.

Shaker A. Mousa, PhD, MBA, FACC, FACB, Seema Mohamed, MS, Laura O’Connor, BS, Eric Block, PhD

Blood (2004) 104 (11): 3924.

https://doi.org/10.1182/blood.V104.11.3924.3924

Published: 2004

NARROW

Targeting Survivin with YM155 As a Potential Therapy in Pediatric Acute Lymphoblastic Leukemia

Curcumin Prevents Cytokine-Mediated Tissue Factor Pathway Inhibitor Down-Regulation in Human Endothelial Cells

Curcumin Down-Regulates Cytokine-Mediated Tissue Factor and Plasminogen Activator Type 1 Expression In Human Endothelial Cells

RNAi Identifies Survivin as a Potential Target for Therapy In Pediatric Acute Lymphoblastic Leukemia

Synergistic Anticancer Effects between Curcumin and Doxorubicin in Drug Sensitive and Resistant Human Pediatric Leukemic Cell Lines.

A Novel Ring-Substituted Diindolylmethane 1,1-bis [3′-(5-methoxyindolyl)]-1-(p-t-butylphenyl) Methane Abrogates ERK Activation and Induces Apoptosis in Acute Myeloid Leukemia (AML).

Sulfur- and Selenium-Containing Compounds Derived from Natural and Synthetic Sources in Angiogenesis Modulation.

Email alerts

ASH Publications

American Society of Hematology

Targeting Survivin with YM155 As a Potential Therapy in Pediatric Acute Lymphoblastic Leukemia

Curcumin Prevents Cytokine-Mediated Tissue Factor Pathway Inhibitor Down-Regulation in Human Endothelial Cells

Curcumin Down-Regulates Cytokine-Mediated Tissue Factor and Plasminogen Activator Type 1 Expression In Human Endothelial Cells

RNAi Identifies Survivin as a Potential Target for Therapy In Pediatric Acute Lymphoblastic Leukemia

Synergistic Anticancer Effects between Curcumin and Doxorubicin in Drug Sensitive and Resistant Human Pediatric Leukemic Cell Lines.

A Novel Ring-Substituted Diindolylmethane 1,1-bis [3′-(5-methoxyindolyl)]-1-(p-t-butylphenyl) Methane Abrogates ERK Activation and Induces Apoptosis in Acute Myeloid Leukemia (AML).

Sulfur- and Selenium-Containing Compounds Derived from Natural and Synthetic Sources in Angiogenesis Modulation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only